| Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B. 1.1. 529) and delta (B. 1.617. 2) variants in England: a cohort study T Nyberg, NM Ferguson, SG Nash, HH Webster, S Flaxman, N Andrews, ... The lancet 399 (10332), 1303-1312, 2022 | 1142 | 2022 |
| Assessing transmissibility of SARS-CoV-2 lineage B. 1.1. 7 in England E Volz, S Mishra, M Chand, JC Barrett, R Johnson, L Geidelberg, ... Nature 593 (7858), 266-269, 2021 | 1111 | 2021 |
| Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity E Volz, V Hill, JT McCrone, A Price, D Jorgensen, Á O’Toole, J Southgate, ... Cell 184 (1), 64-75. e11, 2021 | 1091 | 2021 |
| SARS-CoV-2 evolution during treatment of chronic infection SA Kemp, DA Collier, RP Datir, IATM Ferreira, S Gayed, A Jahun, ... Nature 592 (7853), 277-282, 2021 | 947 | 2021 |
| Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ... The Lancet Infectious Diseases 22 (1), 35-42, 2022 | 829 | 2022 |
| Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, ... The Lancet 397 (10282), 1351-1362, 2021 | 746 | 2021 |
| Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies DA Collier, A De Marco, IATM Ferreira, B Meng, RP Datir, AC Walls, ... Nature 593 (7857), 136-141, 2021 | 702 | 2021 |
| Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity EC Thomson, LE Rosen, JG Shepherd, R Spreafico, A da Silva Filipe, ... Cell 184 (5), 1171-1187. e20, 2021 | 565 | 2021 |
| Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7 B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ... Cell reports 35 (13), 2021 | 435 | 2021 |
| Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK L Du Plessis, JT McCrone, AE Zarebski, V Hill, C Ruis, B Gutierrez, ... Science 371 (6530), 708-712, 2021 | 374 | 2021 |
| Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ... The Lancet Public Health 6 (5), e335-e345, 2021 | 359 | 2021 |
| SARS-CoV-2 within-host diversity and transmission KA Lythgoe, M Hall, L Ferretti, M de Cesare, G MacIntyre-Cockett, ... Science 372 (6539), eabg0821, 2021 | 315 | 2021 |
| Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 E Alm, EK Broberg, T Connor, EB Hodcroft, AB Komissarov, ... Eurosurveillance 25 (32), 2001410, 2020 | 258 | 2020 |
| Generation and transmission of interlineage recombinants in the SARS-CoV-2 pandemic B Jackson, MF Boni, MJ Bull, A Colleran, RM Colquhoun, AC Darby, ... Cell 184 (20), 5179-5188. e8, 2021 | 210 | 2021 |
| SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies MG Cox, TP Peacock, WT Harvey, J Hughes, DW Wright, BJ Willett, ... Nature Reviews Microbiology 21 (2), 112-124, 2023 | 182 | 2023 |
| An integrated national scale SARS-CoV-2 genomic surveillance network COGUK Consortium Microbe, 2020 | 180* | 2020 |
| Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B. 1.617. 2): national case-control study H Allen, A Vusirikala, J Flannagan, KA Twohig, A Zaidi, D Chudasama, ... The Lancet Regional Health–Europe 12, 2022 | 176 | 2022 |
| Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B. 1.1. 7 emergence MUG Kraemer, V Hill, C Ruis, S Dellicour, S Bajaj, JT McCrone, G Baele, ... Science 373 (6557), 889-895, 2021 | 151 | 2021 |
| Patterns of within-host genetic diversity in SARS-CoV-2 G Tonkin-Hill, I Martincorena, R Amato, ARJ Lawson, M Gerstung, ... elife 10, e66857, 2021 | 135 | 2021 |
| Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant P Elliott, D Haw, H Wang, O Eales, CE Walters, KEC Ainslie, C Atchison, ... Science 374 (6574), eabl9551, 2021 | 122 | 2021 |
